Based on a recent article by McKinsey, even though women are largely responsible for consumer healthcare purchasing decisions, women's health has been considered a niche segment. Thankfully, that perception is evolving, leading to improved health outcomes and offering new opportunities in the healthcare industry, including for diagnostics developers and clinical laboratories. How will your organization leverage that change, help enable better outcomes in women's health, and seize on these new opportunities?
Reach the highest confidence.ZeptoMetrix® NATtrol™ Women’s Health & STI products are the most trusted brand in third-party molecular diagnostic QC. Utilizing ZeptoMetrix NATtrol™ Molecular Controls on a consistent basis helps to monitor testing performance and provides additional confidence in the quality and reliability of clinical laboratory operations.
